Okadaic acid stimulates osteopontin expression through de novo induction of AP-1

Journal of Cellular Biochemistry

Volumn 87, Issue 1, 2002, Pages 93-102

  Kim, Hyun Jung ^a   Lee, Mi Hye ^a   Shin, Hong In ^a   Choi, Je Yong ^a,b   Ryoo, Hyun Mo ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

AP 1; Okadaic acid; Osteopontin; Promoter; Tumor

Indexed keywords

OKADAIC ACID; ONCOPROTEIN; OSTEOPONTIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CONSENSUS SEQUENCE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SITE DIRECTED MUTAGENESIS;

3T3 CELLS; ANIMALS; BINDING SITES; BLOTTING, NORTHERN; CELL NUCLEUS; ENZYME INHIBITORS; GENE DELETION; GENES, REPORTER; LUCIFERASES; MICE; MICE, INBRED C3H; MUTAGENESIS, SITE-DIRECTED; OKADAIC ACID; OSTEOBLASTS; OSTEOPONTIN; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SIALOGLYCOPROTEINS; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSFECTION; UP-REGULATION;

EID: 0036354463     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10280     Document Type: Article

References (41)

1. Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity
2. Effect of bFGF on osteopontin gene expression
3. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex
4. Enhancement of VDR-mediated transcription by phosphorylation: Correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex
5. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics
6. The ERR-1 orphan receptor is a transcriptional activator expressed during bone development
7. Inhibitory effect of a marine sponge toxin, okadaic acid, on protein phosphatases
8. 2 vitamin D3 on collagen type I, osteopontin, and osteocalcin gene expression in chicken osteoblasts
9. Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology
10. Okadaic acid inhibits alkaline phosphatase activity in MC3T3-E1 cells
11. Okadaic acid increases fibronectin synthesis in MC3T3-E1 cells
12. Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis
13. Osteopontin expression and function: Role in bone remodeling
14. Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling, and cell survival
15. Osf2/Cbfal: A transcriptional activator of osteoblast differentiation
16. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques
17. Effects of a protein phosphatase inhibitor, okadaic acid, on membrane currents of isolated guinea-pig cardiac myocytes
18. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors
19. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation
20. Altered wound healing in mice lacking a functional osteopontin gene
21. TGF-beta1 modifications in nuclear matrix proteins of osteoblasts during differentiation
22. Overexpression of a single helix-loop-helix-type transcription factor, scleraxis, enhances aggrecan gene expression in osteoblastic osteosarcoma ROS17/2.8 cells
23. Protein serine threonine phosphatases: Structure, regulation, and functions in cell growth
24. Molecular and cellular basis of genetic resistance to bacterial infection: The role of the early T-lymphocyte activation-1/osteopontin gene
25. Tumor-derived osteopontin is soluble, not matrix associated
26. Extracellular signal-regulated kinase 1/2-mediated phosphorylation of JunD and FosB is required for okadaic acid-induced activator protein 1 activation
27. Stage-specific expression of Dlx-5 during osteoblast differentiation: Involvement in regulation of osteocalcin gene expression
28. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues
29. Role of serine/threonine protein phosphatase 2A in cancer
30. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival
31. Protein phosphatase 2A: The Trojan horse of cellular signaling
32. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells
33. Translational regulation is a control point in RUNX2/Cbfal gene expression
34. Okadaicacid, a cytotoxic polyether from two marine sponges of the genus Halichondria
35. Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas
36. The metastasis gene osteopontin: A candidate target for cancer therapy
37. Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor
38. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1
39. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2
40. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption